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Role of the DNA Sensor STING in Protection from Lethal Infection
following Corneal and Intracerebral Challenge with Herpes Simplex
Virus 1
Zachary M. Parker, Aisling A. Murphy,* David A. Leib
Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire, USA
ABSTRACT
STING is a protein in the cytosolic DNA and cyclic dinucleotide sensor pathway that is critical for the initiation of innate re-
sponses to infection by various pathogens. Consistent with this, herpes simplex virus 1 (HSV-1) causes invariable and rapid le-
thality in STING-deficient (STING/) mice following intravenous (i.v.) infection. In this study, using real-time biolumines-
cence imaging and virological assays, as expected, we demonstrated that STING/mice support greater replication and spread
in ocular tissues and the nervous system. In contrast, they did not succumb to challenge via the corneal route even with high ti-
ters of a virus that was routinely lethal to STING/mice by the i.v. route. Corneally infected STING/mice also showed in-
creased periocular disease and increased corneal and trigeminal ganglia titers, although there was no difference in brain titers.
They also showed elevated expression of tumor necrosis factor alpha (TNF-) and CXCL9 relative to control mice but surpris-
ingly modest changes in type I interferon expression. Finally, we also showed that HSV strains lacking the ability to counter au-
tophagy and the PKR-driven antiviral state had near-wild-type virulence following intracerebral infection of STING/mice.
Together, these data show that while STING is an important component of host resistance to HSV in the cornea, its previously
shown immutable role in mediating host survival by the i.v. route was not recapitulated following a mucosal infection route.
Furthermore, our data are consistent with the idea that HSV counters STING-mediated induction of the antiviral state and au-
tophagy response, both of which are critical factors for survival following direct infection of the nervous system.
IMPORTANCE
HSV infections represent an incurable source of morbidity andmortality in humans and are especially severe in neonatal and
immunocompromised populations. A key step in the development of an immune response is the recognition of microbial com-
ponents within infected cells. The host protein STING is important in this regard for the recognition of HSVDNA and the subse-
quent triggering of innate responses. STINGwas previously shown to be essential for protection against lethal challenge from
intravenous HSV-1 infection. In this study, we show that the requirement for STING depends on the infection route. In addition,
STING is important for appropriate regulation of the inflammatory response in the cornea, and our data are consistent with the
idea that HSVmodulates STING activity through inhibition of autophagy. Our results elucidate the importance of STING in
host protection fromHSV-1 and demonstrate the redundancy of host protective mechanisms, especially following mucosal in-
fection.
Herpes simplex virus 1 (HSV-1) is a member of the Alphaher-pesvirus subfamily with high seroprevalence in the human
population (1). Infection at mucosal surfaces such as the mouth,
eyes, and genitalia leads initially to lytic replication in mucosal
epithelial cells, followed by infection of the innervating sensory
neurons. HSV-1 then travels in a retrograde direction to the neu-
ronal cell body, where it establishes latency. It is this ability to
establish latency that renders HSV-1 refractory to clearance by the
immune system, allowing persistence for the lifetime of the host.
During periods of reactivation from latency, HSV-1 can travel in
the anterograde direction to mucosal tissues, causing diseases
ranging in severity from the common cold sore to herpetic stromal
keratitis (HSK), themost common cause of infectious blindness in
the developed world (2). HSV-1 can also gain entry into the cen-
tral nervous system (CNS) to cause herpes simplex encephalitis
(HSE) (3). HSE is a leading cause of viral encephalitis, further
underscoring the significant morbidity and mortality associated
with HSV-1.
In order to effectively respond to infection, host cells have
evolved a broad spectrum of sensors of evolutionarily conserved
pathogen-associated molecular patterns (PAMPS) (for reviews,
see references 4 and 5). To establish a directed and metered anti-
viral state, the cellular responses to viral nucleic acids are particu-
larly important. While responses to endosomal nucleic acids by
Toll-like receptor 3 (TLR3), TLR7, and TLR9 have been well stud-
ied, our understanding of responses to cytosolic nucleic acids is
less developed (4, 6). Such cytoplasmic sensing pathways are can-
didates for efficient sensing of HSV because genomicHSV-1DNA
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is found free in the cytoplasm following proteosomal degradation
of the HSV-1 virion (7). STING (also known as MITA, ERIS, and
TMEM173) is an adaptor protein activated by cytosolic double-
stranded DNA (dsDNA) or cyclic dinucleotides (8–12). Once ac-
tivated, STING translocates to the endoplasmic reticulum, acti-
vating the TBK1/IRF-3 pathway which upregulates interferon
beta (IFN-) (9). In addition, IFI16, a ligand of STING, is a DNA
sensor that presents nuclear and cytoplasmic HSV DNA to
STING, thereby potentiating the STING-dependent sensing of in-
fection (13, 14). Consistent with this, STING is critical for survival
of mice following high-titer intravenous (i.v.) HSV-1 infection
(15). An additional study showed that STING-deficientmice have
increased HSV-1 titers in corneas relative to control mice, but no
further parameters of pathogenesis were measured (16). These
studies confirm a role for STING inHSV infection and collectively
suggest that STING deficiency renders the host highly susceptible
to HSV infection, equivalent perhaps to deficiencies in STAT1,
type I IFN receptors, or IRF-3/7 (17–20). These studies notwith-
standing, how STING-driven responses shape HSV pathogenesis
following peripheral challenge remains unknown. The efficacy of
STING-driven responses to HSV varies by cell type in vitro, which
further complicates predictions of the role of STING in vivo (9, 15,
21). Furthermore, recent work has demonstrated cross talk be-
tween the STING and autophagy pathways and shown it to be
important for activation of IRF-3 (22, 23). These host defenses
notwithstanding, HSV contains a variety of genes that serve to
counter IFN-driven innate responses and autophagy (24–27). The
34.5 gene of HSV-1 is an especially potent neurovirulence factor
in mice and humans that serves to counter the IFN- and protein
kinase PKR-driven antiviral state, as well as strongly modulating
autophagy/xenophagy through a specific interaction with the es-
sential autophagy protein Beclin 1 (24, 28, 29). This provokes the
idea that through 34.5, HSV may thereby inhibit the STING-
driven response through its ability to modulate the autophagy
pathway (30).
In this study, we examined central (intravenous [i.v.] and in-
tracerebral [i.c.]) and peripheral (ocular) routes of HSV-1 infec-
tion in STING-deficient and control mice. In agreement with pre-
vious studies, we found STINGwas essential for control of HSV-1
following central challenge. In contrast to previous studies, how-
ever, STING was dispensable for survival following peripheral
challenge, even with high titers of virus that were routinely lethal
to STING/mice at low i.v. doses.We also demonstrate a role for
tumor necrosis factor alpha (TNF-) and CXCL9 in the increased
pathology observed in STING-deficient mice and show that 34.5
counters both STING-driven antiviral and autophagy responses
in the infected host.
MATERIALS AND METHODS
Viruses, cells, andmice.Vero cells were used to propagate and determine
the titers of viruses as described previously (31). The wild-type (WT)
HSV-1 strains used were strain KOS and strain 17 syn (32, 33). KOS/
Dlux/OriL, the luciferase-expressing HSV strain used for bioluminescent
imaging (BLI), was previously described (34). The 34.5-null virus,
34.5, the 34.5 Beclin-binding domain-deleted virus 68H (termed
herein BBD), and the thymidine kinase null virus 17/tBTK (termed
herein TK) were all on the strain 17 syn background and described
previously (35–37). Heterozygous STING-/ mice in a mixed C57BL/6
and 129SvEv backgroundwere generously provided byGlen Barber (Uni-
versity of Miami) and were described previously (9). This study was car-
ried out in accordance with guidelines set forth by the Guide for the Care
and Use of Laboratory Animals of the National Institutes of Health. Our
protocols were approved by the Dartmouth IACUC (05/06/12, approval
no. leib.da.1).
Animal infection, organ harvest, and periocular disease scoring.
Heterozygous STING/ mice were bred to generate STING/ and
wild-type littermate control mice and genotyped according to methods
and primers described previously (9, 38). Male and female mice, aged 6 to
14 weeks, were anesthetized with intraperitoneal (i.p.) injection of ket-
amine (87 mg/kg body weight) and xylazine (13 mg/kg body weight).
Corneas were scarified in a 10  10 crosshatch pattern, and mice were
either inoculated with 2 106 PFU virus (unless otherwise noted) in 5	l
of inoculation medium (Dulbecco’s modified Eagle’s medium [DMEM;
HyClone] with 2% fetal bovine serum, 60U/ml penicillin [HyClone], and
a 60-	g/ml final concentration of streptomycin [HyClone]) or mock in-
fected with 5 	l of inoculum medium (31). For intracranial infections,
mice were anesthetized as described above and then injected with 1 104
PFU of the indicated virus in 10 	l inoculum medium using a Hamilton
syringe and a 26G needle. For intravenous infections, 1  107 PFU of
strain KOS in a volume of 150 	l was injected directly into tail veins.
Mice were sacrificed at the specified times postinfection or once they
met endpoint criteria as defined by our IACUC protocol. Eye swabs were
collected at indicated time points as previously described (39). Blood was
harvested and serum was separated by centrifugation at 2,000 relative
centrifugal force (RCF) for 5 min and then stored at 80°C. Eye swabs,
spleens, livers, brains, brain stems, and trigeminal ganglia were frozen in
the appropriate volume of inoculation medium at 80°C. Tissues were
prepared for titer determination by homogenization/disruption with
glass beads and sonication as previously described (31).
Micewere scored for disease andweighed at the specified times postin-
fection. Periocular disease scoring was performed as previously described
and summarized here: 0, no pathology; 0.5, minor eyelid swelling; 1.0,
minor eyelid and nasal swelling; 1.5, moderate eyelid and nasal swelling;
2.0, severe eyelid swelling with minor periocular hair loss and skin dam-
age; 3.0, neurological symptoms (20).
IFN- ELISA.Mice were infected as indicated previously, and organs
were harvested, weighed, and placed in extraction reagent I (Invitrogen,
Carlsbad, CA). Organs were homogenized using an electric (Omni Inter-
national, Kennesaw, GA) homogenizer prior to enzyme-linked immu-
nosorbent assay (ELISA). Samples were then centrifuged, and superna-
tants were analyzed using an IFN- ELISA-HS kit according to the
manufacturer’s instructions (PBL Interferon Source, Piscataway, NJ).
Quantitative real-time PCR. Organs were harvested into tissue ex-
traction reagent I (Invitrogen, CA) and then homogenized (Omni Inter-
national, GA) at the time points indicated. RNA was extracted using
TRIzol (Life Technologies, NY) and further purified using an RNeasy kit
(Qiagen). cDNAwas synthesized using SuperScript III (Life Technologies,
NY) and random hexamer primers (Promega, WI). This cDNA was used
for SYBR green real-time PCR (Life Technologies, NY). IFIT1 and TNF-
were measured relative to GAPDH (glyceraldehyde-3-phosphate dehy-
drogenase) using primers as previously described (40, 41) and analyzed
using the 2CT threshold cycle method (42).
Cytokine quantification.Organswere harvested into tissue extraction
reagent (Invitrogen, Carlsbad, CA) and homogenized (Omni Interna-
tional, Kennesaw, GA) at the time points indicated. Cytokines were quan-
tified using a mouse 32-plex Luminex assay (MPXMCYTO70KPMX32;
EMD Millipore, Darmstadt, Germany). CXCL9 levels were further ana-
lyzed using the bead-based cytokine quantification assay Super X-Plex
(Antigenix America, Melville, NY) according to the manufacturer’s in-
structions with samples treated as per the Luminex assay.
BLI. Mice infected corneally with KOS/Dlux/OriL and at the appro-
priate times postinfection were injected i.p. with filter-sterilized D-lucife-
rin potassium salt (Gold Biotech, Olivette, MO) in phosphate-buffered
saline (PBS) at 150 	g/g body weight. Mice were anesthetized with 2.5%
isoflurane and imaged using a cooled charge-coupled device (CCD) cam-
era-equipped instrument (IVIS 100; Caliper LifeSciences, MA) as previ-
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ously described (43). Mice were imaged for 30 s with f-stop 1, binning 8,
and a field of view of 6.6. To quantify luminescent signals, identical re-
gions of interest (ROI) were placed over images encompassing the
mouse’s head from the dorsal view. ROI results were recorded using total
photon flux in photons per second per ROI. All images were analyzed
using Igor Pro Living Image software (version 2.60) (PerkinElmer,
Akron, OH).
RESULTS
STINGisdispensable forprotection fromlethality followingpe-
ripheral HSV-1 infection. We wished to address the hypothesis
that the impact of STING on HSV pathogenesis is dependent on
the route of infection. Previous results demonstrated that infec-
tion of STING/mice was uniformly lethal following i.v. infec-
tion with 1 107 PFUHSV-1 strain KOS, while75% of control
mice survived (15).We wanted to determine whether this mortal-
ity patternwould occur following infection at peripheral sites such
as the cornea, a natural route of infection in humans. Tomatch the
lethal input inoculum of the previously published i.v. study, we
used 1 107 PFU KOS. This dose is significantly higher than that
required for IFN-R/, STAT1/, or IRF-7/mice to suc-
cumb to corneal infection (20, 44). We therefore infected
STING/ and littermate control mice either via the cornea, the
tail vein (i.v.), or the cerebrum (i.c.) with HSV-1 KOS and ob-
served the mice for 21 days or until endpoint health criteria were
reached (Fig. 1A to C). Surprisingly, STING/ and control mice
corneally infected with 1  107 PFU KOS were comparable in
terms of survival, with 1/9 of STING/ mice and 0/11 control
mice reaching endpoint criteria within 21 days (Fig. 1A). In con-
trast, following i.v. infection with 1  107 PFU KOS, 7/8
STING/mice reached endpoint criteria within 7 days relative to
only 3/10 control mice (Fig. 1B). To assess whether STING plays
an important role during infectionwithin tissues of the CNS,mice
were infected i.c. with 1 104 PFUHSV-1KOS.We observed that
13/14 i.c.-infected STING/ mice reached endpoint criteria
within 5 days postinfection (dpi) (Fig. 1C), in stark contrast to
only 1/14 control mice reaching endpoint criteria within the 21-
day experimental period. Consistent with this increasedmortality
following i.c. infection, we also observed significantly increased
viral titers in the brains of STING/mice relative to controlmice
when infected i.c. (Fig. 1D). Taken together, these data confirm
the requirement for STING in protecting the host from HSV-1 in
the CNS. In addition, reduced mortality following peripheral
challenge suggests a STING-independent bottleneck to lethal in-
fection via the cornea when infected with HSV-1 strain KOS.
STING protects the cornea from acute HSV infection but is
not required for viral clearance. To gain a rapid overview of viral
replication and spread we used real-time bioluminescent imaging
(BLI) in conjunction with KOS/Dlux/OriL (KOSDlux), a virus
that expresses firefly luciferase (32, 34). Following corneal infec-
tion with 2  106 PFU/eye of KOSDlux, STING/ and control
mice were imaged daily on days 2 through 9 postinfection (dpi).
Significant luciferase activity above baseline was observed in the
eyes and the skin of the snout of both strains of mice on days 4
through 7 (Fig. 2A) (data not shown). Quantification of the BLI
signals revealed a significantly higher photon flux in the
STING/mice relative to littermate controls over the 9-day time
FIG 1 Survival of STING/ and littermate control mice following corneal, i.v., or i.c. infection. STING/ and control mice were infected with 1 107 PFU
HSV-1 KOS total via the cornea (A) or i.v. (B) or with 1 104 PFUHSV-1 KOS i.c. (C). Survival was recorded until endpoint criteria were met. (D) Brain titers
of STING/ and control mice infected with 1  104 PFU HSV-1 (KOS) i.c. and sacrificed on day 3 postinfection. **, P 
 0.005. Statistical significance was
determined by a Mantel-Cox test, with two independent experiments performed with9 mice.
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course (Fig. 2B). Despite this increase, photon flux in both the
STING/ and wild-type mice returned to baseline on day 9, in-
dicating both strains of mice were able to clear the infection in the
cornea (Fig. 2B). Consistent with this, the visceral dissemination
and mortality previously observed with corneal KOSDLux infec-
tion of IFN-R / and STAT1/ mice was not observed in
STING/ mice (44). These results demonstrate that while
STING plays a role in the control of corneal HSV-1 infection, it is
dispensable for the clearance of virus from the cornea and from
tissues subsequently infected via this route.
To confirm and extend our BLI results to tissues that cannot be
easily imaged, STING/ mice and littermate controls were cor-
neally infected with 2  106 PFU/eye of HSV-1 KOS, and viral
titers were quantified in corneas, brain, brain stem, liver, spleen,
lymph nodes, and serum. STING/ mice had significantly in-
creased viral titers compared to control mice in both eyes and
trigeminal ganglia (Fig. 3A and B). Viral loads within the brain
stem (Fig. 3C) and brain tissues (Fig. 3D) did not significantly
differ between control and STING/mice, confirming that there
is no additional dissemination through the tissues of the CNS
following peripheral infection. This was in contrast to mice that
were infected i.c., in which there were significantly increased titers
in the brains of STING/mice (Fig. 1D). Virus was not detected
in the serum, lymph nodes, spleens, or livers of STING/ or
control mice on days 3 and 5 postinfection (data not shown),
confirming the lack of visceral dissemination following peripheral
challenge.
Given the increased titers in corneas and trigeminal ganglia of
STING/ mice, we wished to assess whether these mice would
also exhibit altered periocular disease or weight loss (Fig. 3E and
F). Periocular disease scores were significantly higher for
STING/mice than for control mice on 6 of 10 days monitored
postinfection, and at all time points, the mean disease scores were
higher for the STING/mice. Theweight loss of STING/mice
was overall greater than that in control mice, although it failed to
reach statistical significance except for 8 days postinfection. Taken
together, these data suggest that there is STING-dependent con-
trol of viral replication in the cornea but that STING is dispensable
for viral clearance. Moreover, STING deficiency is associated with
significantly increased periocular disease.
Interferon responses of STING/ mice following corneal
infection. STING acts as an adaptor that bridges cytosolic DNA
sensing with upregulation of IFN-—a critical cytokine in host
defense to viral infection (45–47). We observed in this study that
the survival of STING/mice was dependent upon the route of
infection. We therefore hypothesized that the survival differences
observed in STING/mice might result from anatomically dis-
tinct patterns of IFN- signaling. To test this hypothesis, we ocu-
FIG 2 Bioluminescent imaging (BLI) and quantification of HSV-1 (KOSDlux) in STING/ and littermate control mice following corneal infection. (A) BLI of
STING/ and control mice following corneal infection with 2  106 PFU/eye KOSDLux. All images are formatted to a log scale with a minimum 5  104
photons (p)/s/cm2/sr (purple) andmaximumof 1 106 p/s/cm2/sr (red). (B)Quantification of total photon flux performed on heads of all animals imaged using
region of interest (ROI) analysis in Living Image software (Xenogen). Data show significant differences between STING/ and control mice using area under
the curve analysis and an unpaired two-tailed t test (P 0.0171). Results are from three independent experiments with9 mice.
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larly infected STING/ and control mice with HSV-1 KOS and
measured IFN- in the cornea by ELISA (Fig. 4A). At 3 days post-
corneal infection, IFN- levels were significantly elevated in in-
fected relative to mock-infected corneas. Surprisingly, IFN- lev-
els were slightly higher in the STING/ corneas relative to those
of the littermate controls (Fig. 4A). We also measured IFN- lev-
els in brain tissue of mice following intracranial infection with
HSV-1 KOS. Again, at 3 days post-i.c. infection, IFN- levels were
significantly elevated in infected relative to mock-infected brains
(Fig. 4B). Consistent with previous studies, slightly lower levels of
IFN- were observed in STING/ mice compared to littermate
controls (15). To furthermeasure IFN synthesis following corneal
and i.c. infections at earlier timepoints, we alsomeasured IFNat 2,
4, 6, and 8 h postinfection, but all samples were at or below the
level of detection of the ELISA (data not shown).
Although these differences in IFN- levels in the corneas and
brains of STING/ relative to control mice were statistically sig-
nificant (P
 0.05), themagnitude of these changes seemed insuf-
ficient to explain the differences in viral pathogenesis observed.
Nonetheless, it was possible that small changes in IFN- levels
could have a disproportionate effect on downstream antiviral
IFN-stimulated genes (ISGs). Furthermore, the sensitivity of
ELISA for detecting IFN- could be limiting since the values ob-
tained were close to the limits of detection. To examine this fur-
ther, induction of the ISG IFIT1 was measured using real-time
PCR. Consistent with the patterns seen with IFN-, there was
strong induction of IFIT1 expression in corneas and brains of all
infected mice (both STING/ and WT), relative to mock-in-
fected mice (Fig. 4C and D). Furthermore, levels of IFIT1 expres-
sion were statistically indistinguishable in STING/ and control
mice. Together, these data are consistent with the idea that the
increased pathology and lethality caused by HSV infection in
STING/ relative to control mice are largely independent of the
expression and downstream effects of IFN-.
Other cytokine responses in STING/mice. Given that the
different survival phenotypes arising in STING/ and control
mice following central or peripheral HSV-1 infection appeared to
be independent of IFN synthesis, we hypothesized that a dysregu-
lated immune responsemay be causing the pathology observed. A
key early regulator that mediates corneal damage during HSV-1
infection is tumor necrosis factor alpha (TNF-) (48, 49). Using
real-time PCR, we measured TNF- expression in corneas dis-
sected from STING/ and control mice infected with HSV-1
KOS on day 3 postinfection (Fig. 5A). TNF- expression was sig-
nificantly elevated in corneas of STING/mice relative to those
of control or mock-infected mice. Following i.c. infection, how-
ever, the levels of TNF- expression were comparable in
STING/ and control mice (Fig. 5B). To further probe potential
chemokines and cytokines thatmay contribute to the outcomes of
corneal and i.c. infection of STING/ and control mice, we per-
formed a 32-plex Luminex screen (data not shown). The corneas
of corneally infected STING/mice showed a particularly strong
increase in the chemokine CXCL9 (Fig. 5C), consistent with the
observation that that infected STING/ corneas exhibit in-
FIG 3 Viral titers of STING/ and littermate control mice following corneal infection with 2 106 PFU/eye of HSV-1 (KOS). Mice sacrificed on days 3 and
5 were used to collect titer data for eye swabs (A), trigeminal ganglia (B), brain stems (C), and brains (D). Periocular disease (E) and weight change (F) of
STING/ and control mice were measured by a masked observer (20). **, P 
 0.005; ***, P 
 0.0005. Statistical significance was tested using an unpaired
two-tailed t test for each day. Disease scores and weights postinfection were measured during two independent experiments, using a total of 14 to 23 mice per
group.
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creased inflammation. In contrast, wild-type and STING/mice
infected i.c. showed comparable levels of brainCXCL9 expression,
although both groups had elevated CXCL9 compared to mock-
infected mice (Fig. 5D). Corneas of STING/ mice therefore
exhibit elevated inflammatory cytokine responses toHSV-1 infec-
tion. In contrast, there were no demonstrable differences in in-
flammatory cytokines between STING/ and control mice fol-
lowing i.c. infection.
Virulence of34.5-deficient viruses is restored in STING/
mice following i.c. infection. The STING-driven antiviral re-
sponse in infected cells activates and is modulated by autophagy
(22, 23, 30, 50). Given the autophagy-modulating role of HSV-1
34.5, it was of interest to examine its role in modulating the
effects of STING (24).We used two different recombinant viruses
(34.5 and BBD) with mutations in the 34.5 gene. 34.5 lacks
the entire 34.5 open reading frame (ORF) and is thereby unable
to block the IFN- and PKR-driven antiviral response and cannot
counter autophagy (35, 36, 51).BBD is fully capable of blocking
the IFN- and PKR-driven antiviral response but cannot block au-
tophagy because the Beclin-binding domain of 34.5 has been
deleted (34). As a control, we also used 17TK (17/tBTK), which
lacks the viral thymidine kinase gene (37). 17TK is highly atten-
uated in vivo through a pathway unrelated to IFN responses or
autophagy and therefore served to test the caveat that STING de-
ficiency may nonspecifically increase or restore the virulence of
any attenuated virus. All viruses used in these experiments were in
the strain 17 background. While strain 17 has higher virulence
than KOS, the mutant viruses are profoundly attenuated. To in-
crease the probability of determining a clear phenotype with these
strain 17 mutants, we therefore used a higher inoculum (2 104
PFU) in these i.c. experiments than in those with KOS shown in
Fig. 1C and D. For consistency within this experiment, we also
used this higher inoculum with WT strain 17 (Fig. 6). Control
mice showed a significant (P
 0.02) survival advantage compared
to STING/mice, although all mice reached endpoint criteria by
6 days postinfection (Fig. 6A). When lower doses of strain 17 (50
PFU) were administered, 82% of STING/ and 91% of control
mice succumbed to infection, although a significant survival ad-
vantage for control mice was again observed (P
 0.02) (data not
shown), consistent with the data for KOS (Fig. 1C). To test
FIG 4 Interferon responses following corneal or intracranial HSV-1 KOS infection. (A) IFN- ELISA of STING/ and control corneas 3 days following
infection with 2  106 PFU/eye HSV-1 KOS. (B) IFN- ELISAs on STING/ and littermate control brains 3 days following i.c. infection with 1  104 PFU
HSV-1 KOS. (C) Real-time PCR of IFIT1mRNA expression relative to that in control mock-infected mice normalized to GAPDH in the corneas of STING/
and control mice 3 days post-corneal infection with 2  106 PFU/eye HSV-1 KOS. (D) Real-time PCR of IFIT1 mRNA expression relative to that in control
mock-infected mice normalized to GAPDH in the brains of STING/ and littermate control mice 3 days post-i.c. infection with 1 104 PFU/eye HSV-1 KOS.
*, P
 0.05. Statistical significance was determined using an unpaired two-tailed t test for IFN- ELISAs and IFIT1mRNA expression results. IFN- ELISAs were
carried out in two independent experiments on a total number of mice as follows: corneal infection, WT, n 7, and STING/, n 7; i.c. infection, WT, n
12, and STING/, n 14. IFIT1 real-time PCR was carried out in two independent experiments on a total of 7 mice per group.
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whether STING-dependent antiviral responses against HSV were
dependent on autophagy and whether HSV can counter this re-
sponse, we infected STING/ and control mice i.c. with BBD
(Fig. 6B). As previously shown,BBDwas significantly attenuated
in control animals relative to strain 17, with only 50% of mice
reaching endpoint criteria within 21 days (28). In contrast, in
STING/ mice, the virulence of BBD was significantly in-
creased compared to that of littermate controls, with all
STING/mice succumbing to infection within 8 days. We next
infected mice with the 34.5 null mutant (34.5), which cannot
modulate autophagy and is unable to dephosphorylate the  sub-
unit of eukaryotic initiation factor 2 (eIF2) to prevent host-im-
posed translational arrest (29, 52). Upon infection of controlmice
with 34.5, there was profound attenuation, with all control
mice surviving infection to 21 days (Fig. 6C). In contrast, all
STING/ mice succumbed to infection with 34.5 within 9
days (Fig. 6C), with kinetics that were statistically indistinguish-
able from those following infection withBBD (Fig. 6B). To con-
firm that these changes in virulence in STING/mice were spe-
cific to the IFN and autophagy pathways, we infected STING/
mice and controls with TK (Fig. 6D). We observed complete
survival of both wild-type and STING/ mice over the 21-day
infection period, supporting the idea that the attenuation of the
34.5 mutants is largely due to their inability to counteract the
STING-dependent autophagy pathway.
To further understand the role of STING in corneal infection,
STING/ and littermate control mice were infected corneally
with the strain 17,34.5,BBD, andTKviruses. The inoculum
used for all experiments was 1 105 PFU/eye, as strain 17 is more
neurovirulent than strain KOS. Following HSV-1 strain 17 cor-
neal infection, all STING/ mice and 57% of control mice suc-
cumbed to infection (Fig. 7A). To test whether HSV-1 counters
this STING-dependent autophagic response through the BBDdo-
main of 34.5, we infected mice corneally with BBD (Fig. 7B).
All STING/mice succumbed to this infection by day 11 postin-
fection, while all control mice survived the challenge. The compa-
rable endpoint of STING/ mice infected with strain 17 and
BBD, along with the increased survival of control mice, demon-
strates that the HSV-1 34.5 BBD is most likely countering the
STING-dependent autophagy response following corneal infec-
tion. STING/ and control mice infected with 34.5 showed
no statistically significant difference in survival (Fig. 7C). To con-
firm these results were specific to the autophagy and IFN path-
ways, we corneally infected STING/ and controlmicewithTK
FIG 5 Cytokine RNA expression in infected STING/ and littermate control mice 3 days postinfection. (A and B) Real-time PCR of TNF-mRNA expression
relative to that in controlmock-infectedmice performed on the excised corneas of STING/ and controlmice 3 days postinfectionwith 2 106 PFU/eyeHSV-1
KOS (A) or excised brains ofmice 3 days post-intracranial infection with 1 104 PFUHSV-1 KOS (B). (C andD) Luminex analysis of CXCL9 in corneas ofmice
3 days post-corneal infection with 2 106 PFU/eye HSV-1 KOS (C) or brains of mice 3 days post-intracranial infection with 1 104 PFU HSV-1 KOS (D). *,
P
 0.05. Statistical significance was determined using an unpaired two-tailed t test for TNF- expression and CXCL9 concentration results. TNF- real-time
PCR and CXCL9 cytokine quantification were carried out in two independent experiments on a total of 5 mice per group.
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(Fig. 7D). We found that all mice survived the TK corneal chal-
lenge. Together with Fig. 1, these data suggest that neurovirulent
strains of HSV-1 can overcome the corneal STING-independent
barrier to cause significant mortality and that protection is medi-
ated at least partially by STING.
DISCUSSION
STING is pivotal in the innate response to a variety of patho-
gens (15, 50, 53, 54). This is largely through its ability to rec-
ognize cytosolic dsDNA and subsequently interact with TBK,
facilitating phosphorylation of IRF-3 and induction of IFN-
dependent antiviral responses. Consistent with these activities,
STING is indispensable for the protection of mice from HSV-
1-induced mortality following intravenous challenge with the
low-virulence HSV-1 KOS strain (15). The studies described
herein are consistent with these findings, but our use of a mu-
cosal route of infection via the cornea has revealed that STING
is dispensable for survival following a peripheral challenge with
KOS. These findings contrast with studies of other mediators of
the IFN response, such as STAT1 and IFN receptors, which are
essential for prevention of generalized infection and mortality
following peripheral challenge with KOS. Our findings also
provide an interesting contrast with mice deficient in IRF-3
which were originally shown to be completely resistant to chal-
lenge by intravenous HSV-1 but subsequently shown to be sus-
ceptible to lethal infection via the corneal and i.c. routes (55,
56). These data therefore underscore the importance of testing
immune-deficient mice using a variety of infection routes. Fur-
thermore, they show that even when the immune deficiencies
are in the same antiviral pathways, different and unexpected
resistance patterns can emerge.
IFN responses are a key determinant of the outcome of cor-
neal infection by HSV-1. In this study, STING/ mice exhib-
ited increased ocular titers relative to controls, consistent with
previous studies (16). Using IVIS imaging, we were able to
extend these observations and visualize viral tropism over a
longer time course, allowing us to observe a more robust ocular
infection in STING/mice but with eventual clearance of the
virus. This pattern was predicted based on previous studies, but
it was unexpected that the altered titers were largely indepen-
dent of IFN production in the tissues examined. One possible
explanation is that the STING pathway induces autophagy,
which in turn controls virus replication in the cornea (22, 23).
STING/mice may therefore have a reduced ability to control
HSV through autophagy/xenophagy in the cornea, and as dis-
cussed further below, this may also apply to infection of CNS
tissues. It was also notable that STING/ mice had greater
periocular disease scores than control mice. This was consis-
tent with increased TNF- expression and CXCL9 concentra-
tion in the corneas of STING/ mice. Given that STING up-
regulates the expression of TNF-, it seems likely that the
increased TNF- expression in STING/ mice results indi-
rectly from increased viral titers rather than being a direct con-
sequence of STING deficiency (57). Histology performed on
corneas of infected mice revealed increased immune cell infil-
tration in the corneas of STING/mice compared to controls
(data not shown), consistent with the increases in observed
TNF- and CXCL9. While STING is clearly dispensable for
FIG 6 Survival analysis of STING/ and littermate control mice following intracranial infection with 2 104 PFU of HSV-1 strain 17 (A), BBD (B), 34.5
(C), and TK (D). Mortality was recorded upon endpoint criteria being met. Statistical significance was determined by a Mantel-Cox test. For each type of
infection, two independent experiments were performed. The numbers of mice used for each survival experiment are as follows: strain 17, WT, n  6, and
STING/, n 10; BBD, WT, n 6, and STING/, n 7; 34.5, WT, n 9, and STING/, n 10; and TK, WT, n 11, and STING/, n 8.
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mediating survival following corneal infection with strain
KOS, it is important for limiting HSV replication in the cornea
and thereby necessary to avoid the induction of immunopatho-
logical cytokine expression and subsequent periocular disease.
These findings are consistent with previous data showing in-
creased and protracted genital inflammation in STING/
mice following vaginal infection, although no survival data
were presented (15). Furthermore, it has been observed during
skin infections with HSV-1 that while STING/ mice have
higher viral titers in the skin, virus is not found in the brain and
STING/ mice do not succumb to infection (S. Bedoui, per-
sonal communication).
The patterns of HSV replication and virulence in the brains of
STING/ mice in this study appear to be determined largely by
the route of infection. Following corneal infection with HSV-1
KOS, despite significantly increased titers in the cornea and tri-
geminal ganglia of STING/ mice, there was no difference in
viral replication in the brain or statistically discernible changes in
survival. Furthermore, analysis of brain cytokines by BioPlex and
ELISA on days 3 and 5 post-corneal infection showed no signifi-
cant changes (data not shown). In contrast, following i.c. infection
of STING/ mice with HSV-1 KOS, we observed significant
changes in viral replication in the brain, proinflammatory cyto-
kine production, and survival. Both i.c. infections with KOS and
strain 17 demonstrated a significant survival advantage for control
relative to STING/mice. This survival advantage is greater for
KOS, as expected given its reduced neurovirulence relative to
strain 17, but both survival phenotypes are representative of the
importance of STING when natural barriers to infection are
breached. When the neurovirulent strain 17 was used in corneal
infections, 50% of control mice and 100% of STING/ mice
succumbed to the infection, demonstrating that neurovirulence of
the virus can overcome the corneal replication bottleneck. It is
possible that once themore neurovirulent virus is able to reach the
brain, a STING-dependent response is necessary to control the
virus: therefore, STING/ mice readily succumb to infection,
although with the high neurovirulence of strain 17, even half of
control mice succumb to infection. These data suggest a CNS-
specific requirement for STING to promote host survival. The
requirement for STING in the CNS, however, appeared largely
independent of IFN since there were only modest changes in
IFN- and no differences in ISG (IFIT1) expression between
STING/ and control mice after i.c. infection with KOS. These
findings are consistent with the data and hypothesis that the ner-
vous system largely utilizes nondestructive innate responses to
infection, such as autophagy/xenophagy (58, 59). This mode of
pathogen clearance preserves the viability of neurons, which are
largely a nonreplicating irreplaceable population of cells. IFN-
driven antiviral responses are therefore necessarily muted or inef-
fective in the nervous system, and xenophagy is a dominant anti-
viral defense in both the peripheral nervous system (PNS) and
CNS. It is also of note that there were no discernible differences in
the ability of HSV-1 to reactivate from latently infected trigeminal
ganglia explanted from STING/ or control mice (data not
shown). The relationship between STING and autophagy is com-
plex and an area of a great deal of recent research. There is clear
FIG 7 Survival analysis of STING/ and littermate control mice following corneal infection with 1 105 PFU/eye of HSV-1 strain 17 (A), BBD (B), 34.5
(C), andTK (D).Mortality was recorded upon endpoint criteria beingmet. Statistical significancewas determined by aMantel-Cox test. For each infection, two
independent experiments were performed. The numbers of mice used for each survival experiment are as follows: strain 17, WT, n 7, and STING/, n 7;
BBD, WT, n 6, and STING/, n 6; 34.5, WT, n 5, and STING/, n 6; and TK, WT, n 4, and STING/, n 5.
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evidence, however, that in addition to stimulating the IFN-driven
antiviral response, STING-dependent responses also stimulate the
xenophagy pathway that promotes the clearance of intracellular
pathogens (60). Indeed, STING is critical for the HSV-induced
autophagy response, at least in bone marrow-derived dendritic
cells (BMDCs) (61). Notably, STING transcription is low in cor-
nea andbrain tissues but high in antigen-presenting cells, cells that
undergo significant autophagic flux (62, 63). The data described
herein strongly implicate that HSV 34.5 counters the antiviral
effects of STING largely through its ability tomodulate autophagy
through binding to Beclin 1 rather than altering IFN responses
through its ability to bind TBK, eIF2, or PP1 (22, 24, 28, 29, 52,
64). Further support for this idea comes from studies in our
laboratory showing that levels of IRF-3 phosphorylation,
largely mediated by TBK, are comparable between BBD and
wild-type viruses (R. Manivanh and D. A. Leib, unpublished
data). Data from this study are consistent with the idea that
while the STING-driven IFN-dependent response is important
in vivo in some instances, the STING-dependent activation in
autophagy and xenophagy is also a critical antiviral mecha-
nism, especially in the CNS. Both of these responses are pow-
erfully countered by 34.5 and likely by other viral factors, such
as ICP0 and US11, which act in concert to regulate the intricate
life cycle of HSV-1 (26, 27, 65).
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